MiddleBrook Pharmaceuticals (MBRK) gapped open lower amid heavy volume but moved sideways throughout most of Wednesday's trading. The plunge came after the company announced a $100 million investment from EGI and the resignation of its President and CEO.
The stock broke support and fell below its 200-day moving average. Shares closed at their lowest level since late January, down $1.50 at $1.57.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.